View Item 

Show simple item record

Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)
dc.contributor.authorSylvia, Louisa Gen_US
dc.contributor.authorShelton, Richard Cen_US
dc.contributor.authorKemp, David Een_US
dc.contributor.authorBernstein, Emily Een_US
dc.contributor.authorFriedman, Edward Sen_US
dc.contributor.authorBrody, Benjamin Den_US
dc.contributor.authorMcElroy, Susan Len_US
dc.contributor.authorSingh, Viveken_US
dc.contributor.authorTohen, Mauricioen_US
dc.contributor.authorBowden, Charles Len_US
dc.contributor.authorKetter, Terence Aen_US
dc.contributor.authorDeckersbach, Thiloen_US
dc.contributor.authorThase, Michael Een_US
dc.contributor.authorReilly‐harrington, Noreen Aen_US
dc.contributor.authorNierenberg, Andrew Aen_US
dc.contributor.authorRabideau, Dustin Jen_US
dc.contributor.authorKinrys, Gustavoen_US
dc.contributor.authorKocsis, James Hen_US
dc.contributor.authorBobo, William Ven_US
dc.contributor.authorKamali, Masouden_US
dc.contributor.authorMcInnis, Melvin Gen_US
dc.contributor.authorCalabrese, Joseph Ren_US
dc.date.accessioned2015-04-02T15:12:27Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-03en_US
dc.identifier.citationSylvia, Louisa G; Shelton, Richard C; Kemp, David E; Bernstein, Emily E; Friedman, Edward S; Brody, Benjamin D; McElroy, Susan L; Singh, Vivek; Tohen, Mauricio; Bowden, Charles L; Ketter, Terence A; Deckersbach, Thilo; Thase, Michael E; Reilly‐harrington, Noreen A ; Nierenberg, Andrew A; Rabideau, Dustin J; Kinrys, Gustavo; Kocsis, James H; Bobo, William V; Kamali, Masoud; McInnis, Melvin G; Calabrese, Joseph R (2015). "Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)." Bipolar Disorders 17(2): 212-223.en_US
dc.identifier.issn1398-5647en_US
dc.identifier.issn1399-5618en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110852
dc.publisherNew York State Psychiatric Instituteen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.othermood symptomsen_US
dc.subject.othermetabolic syndromeen_US
dc.subject.othermedical comorbidityen_US
dc.subject.otherbipolar disorderen_US
dc.titleMedical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110852/1/bdi12243.pdf
dc.identifier.doi10.1111/bdi.12243en_US
dc.identifier.sourceBipolar Disordersen_US
dc.identifier.citedreferenceSuppes T, Dennehy EB, Hirschfeld RM et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66: 870 – 886.en_US
dc.identifier.citedreferenceHennekens C. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry 2007; 68 ( Suppl. 4 ): 4 – 7.en_US
dc.identifier.citedreferenceAngst F, Stassen HH, Clayton PJ et al. Mortality of patients with mood disorders: follow‐up over 34–38 years. J Affect Disord 2002; 68: 167 – 181.en_US
dc.identifier.citedreferenceOsby U, Brandt L, Correia N et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844 – 850.en_US
dc.identifier.citedreferenceFagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 2009; 70 ( Suppl. 3 ): 22 – 29.en_US
dc.identifier.citedreferenceCentorrino F, Mark TL, Talamo A et al. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder. J Clin Psychopharmacol 2009; 29: 595 – 600.en_US
dc.identifier.citedreferenceKemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 2010; 12: 404 – 413.en_US
dc.identifier.citedreferenceThompson WK, Kupfer DJ, Fagiolini A et al. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute‐phase data from a randomized controlled trial. J Clin Psychiatry 2006; 67: 783 – 788.en_US
dc.identifier.citedreferenceLindenmayer JP, Khan A, Kaushik S et al. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophr Res 2012; 142: 171 – 176.en_US
dc.identifier.citedreferenceGili M, Garcia‐Toro M, Vives M et al. Medical comorbidity in recurrent versus first‐episode depressive patients. Acta Psychiatr Scand 2011; 123: 220 – 227.en_US
dc.identifier.citedreferenceChang HH, Yang YK, Gean PW et al. The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord 2010; 124: 319 – 323.en_US
dc.identifier.citedreferenceLee NY, Kim SH, Cho B et al. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1243 – 1249.en_US
dc.identifier.citedreferenceSerretti A, Chiesa A, Calati R et al. Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. J Psychopharmacol 2013; 27: 616 – 628.en_US
dc.identifier.citedreferencede Almeida KM, Moreira CL, Lafer B. Metabolic syndrome and bipolar disorder: what should psychiatrists know? CNS Neurosci Ther 2012; 18: 160 – 166.en_US
dc.identifier.citedreferenceKetter TA. Strategies for monitoring outcomes in patients with bipolar disorder. Prim Care Companion J Clin Psychiatry 2010; 12 ( Suppl. 1 ): 10 – 16.en_US
dc.identifier.citedreferenceOrtiz A, Cervantes P, Zlotnik G et al. Cross‐prevalence of migraine and bipolar disorder. Bipolar Disord 2010; 12: 397 – 403.en_US
dc.identifier.citedreferenceLala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 2012; 25: 20 – 25.en_US
dc.identifier.citedreferenceKilbourne AM, Post EP, Nossek A et al. Service delivery in older patients with bipolar disorder: a review and development of a medical care model. Bipolar Disord 2008; 10: 672 – 683.en_US
dc.identifier.citedreferenceNierenberg AN, Sylvia LG, Leon AC et al. Clinical Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials 2014; 11: 114 – 127.en_US
dc.identifier.citedreferenceAsao K, Kao WH, Baptiste‐Roberts K et al. Short stature and the risk of adiposity, insulin resistance, and type 2 diabetes in middle age: the Third National Health and Nutrition Examination Survey (NHANES III), 1988‐1994. Diabetes Care 2006; 29: 1632 – 1637.en_US
dc.identifier.citedreferenceSheehan DV, Lecrubier Y, Sheehan KH et al. The Mini‐International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM‐IV and ICD‐10. J Clin Psychiatry 1998; 59 ( Suppl. 20 ): 22 – 33.en_US
dc.identifier.citedreferenceSpearing MK, Post RM, Leverich GS et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI‐BP. Psychiatry Res 1997; 73: 159 – 171.en_US
dc.identifier.citedreferenceBowden CL, Singh V, Thompson P et al. Development of the bipolar inventory of symptoms scale. Acta Psychiatr Scand 2007; 116: 189 – 194.en_US
dc.identifier.citedreferenceGonzalez JM, Bowden CL, Katz MM et al. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res 2008; 17: 198 – 209.en_US
dc.identifier.citedreferenceLeon AC, Solomon DA, Mueller TI et al. A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE‐RIFT. Longitudinal Interval Follow‐up Evaluation‐Range Impaired Functioning Tool. J Nerv Ment Dis 2000; 188: 805 – 812.en_US
dc.identifier.citedreferenceKilbourne AM, Cornelius JR, Han X et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004; 6: 368 – 373.en_US
dc.identifier.citedreferencePark YW, Zhu S, Palaniappan L et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427 – 436.en_US
dc.identifier.citedreferenceThabit H, Burns N, Shah S et al. Prevalence and predictors of diabetes and cardiometabolic risk among construction workers in Ireland: the Construction Workers Health Trust screening study. Diab Vasc Dis Res 2013; 10: 337 – 345.en_US
dc.identifier.citedreferenceDijk FN, de Jongste JC, Postma DS et al. Genetics of onset of asthma. Curr Opin Allergy Clin Immunol 2013; 13: 193 – 202.en_US
dc.identifier.citedreferenceWober‐Bingol C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 2013; 17: 341.en_US
dc.identifier.citedreferenceGelfand AA. Migraine and childhood periodic syndromes in children and adolescents. Curr Opin Neurol 2013; 26: 262 – 268.en_US
dc.identifier.citedreferenceVogelzangs N, Kritchevsky SB, Beekman AT et al. Obesity and onset of significant depressive symptoms: results from a prospective community‐based cohort study of older men and women. J Clin Psychiatry 2010; 71: 391 – 399.en_US
dc.identifier.citedreferencevan Reedt Dortland AK, Giltay EJ, van Veen T et al. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010; 122: 30 – 39.en_US
dc.identifier.citedreferenceMitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 2008; 10: 144 – 152.en_US
dc.identifier.citedreferenceSylvia LG, Friedman ES, Kocsis JH et al. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. J Affect Disord 2013; 151: 722 – 727.en_US
dc.identifier.citedreferenceSylvia LG, Salcedo S, Bernstein EE et al. Nutrition, exercise, and wellness treatment in bipolar disorder: proof of concept for a consolidated intervention. Int J Bipolar Disord 2013; 1: 24.en_US
dc.identifier.citedreferenceFiedorowicz JG, Solomon DA, Endicott J et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009; 71: 598 – 606.en_US
dc.identifier.citedreferenceFeldman NS, Gwizdowski IS, Fischer EG et al. Co‐occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: a case series. J Clin Psychiatry 2012; 73: 874 – 877.en_US
dc.identifier.citedreferencePosner K, Brent D, Lucas C et al. Columbia Suicide Severity Rating Scale (C‐SSRS). New York, NY: New York State Psychiatric Institute, 2009.en_US
dc.identifier.citedreferenceSalvatore P, Tohen M, Khalsa HM et al. Longitudinal research on bipolar disorders. Epidemiol Psichiatr Soc 2007; 16: 109 – 117.en_US
dc.identifier.citedreferenceYoung AH, Grunze H. Physical health of patients with bipolar disorder. Acta Psychiatr Scand Suppl 2013; 442: 3 – 10.en_US
dc.identifier.citedreferenceCoryell W, Scheftner W, Keller M et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150: 720 – 727.en_US
dc.identifier.citedreferenceSanchez‐Moreno J, Martinez‐Aran A, Tabares‐Seisdedos R et al. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 2009; 78: 285 – 297.en_US
dc.identifier.citedreferenceTohen M, Waternaux CM, Tsuang MT. Outcome in mania. A 4‐year prospective follow‐up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106 – 1111.en_US
dc.identifier.citedreferenceKemp DE, Sylvia LG, Calabrese JR et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand 2014; 129: 24 – 34.en_US
dc.identifier.citedreferenceMaina G, Bechon E, Rigardetto S, Salvi V. General medical conditions are associated with delay to treatment in patients with bipolar disorder. Psychosomatics 2013; 54: 437 – 442.en_US
dc.identifier.citedreferenceWeber NS, Fisher JA, Cowan DN et al. Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey. Psychiatr Serv 2011; 62: 1152 – 1158.en_US
dc.identifier.citedreferenceGoldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009; 11: 657 – 662.en_US
dc.identifier.citedreferenceKhot UN, Khot MB, Bajzer CT et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290: 898 – 904.en_US
dc.identifier.citedreferenceMcIntyre RS, Konarski JZ, Misener VL et al. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005; 17: 83 – 93.en_US
dc.identifier.citedreferenceKrishnan KR. Psychiatric and medical comorbidity of bipolar disorder. Psychosom Med 2005; 67: 1 – 8.en_US
dc.identifier.citedreferenceSoreca I, Fagiolini A, Frank E et al. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008; 42: 956 – 961.en_US
dc.identifier.citedreferenceMcIntyre RS, Konarski JZ, Soczynska JK et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv 2006; 57: 1140 – 1144.en_US
dc.identifier.citedreferenceKemp DE, Gao K, Ganocy SJ et al. Medical and substance use comorbidity in bipolar disorder. J Affect Disord 2009; 116: 64 – 69.en_US
dc.identifier.citedreferenceKupka RW, Nolen WA, Post RM et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002; 51: 305 – 311.en_US
dc.identifier.citedreferenceMatthews AM, Huckans MS, Blackwell AD, Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 2008; 10: 266 – 270.en_US
dc.identifier.citedreferencevan Winkel R, De Hert M, Van Eyck D et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008; 10: 342 – 348.en_US
dc.identifier.citedreferenceGoldstein BI, Liu SM, Zivkovic N, Schaffer A, Chien LC, Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 2011; 13: 387 – 395.en_US
dc.identifier.citedreferenceMcElroy SL, Frye MA, Suppes T et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002; 63: 207 – 213.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bdi12243.pdf
Size:
225.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.